WASHINGTON, July 23 [Category: Sociological] -- The National Organization for the Reform of Marijuana Laws posted the following news release:

* * *

Clinical Trial: THC/CBD Formulation Reduces Alzheimer's-Induced Agitation

*

London, United Kingdom: The oral administration of a standardized formulation of THC and CBD significantly reduces agitation in patients with late-stage Alzheimer's disease, according to clinical trial data present . . .

Click here for more information about our products